During CRC progression, oncogenic KRAS activates AKT and ERK signaling, increasing c-Myc-mediated MTHFD2 expression to maintain NADPH homeostasis, which has been linked to cell survival [125]. The gene discussed is KRAS; the disease is colorectal carcinoma.